346 related articles for article (PubMed ID: 22547543)
1. Surfactant protein D facilitates Cryptococcus neoformans infection.
Geunes-Boyer S; Beers MF; Perfect JR; Heitman J; Wright JR
Infect Immun; 2012 Jul; 80(7):2444-53. PubMed ID: 22547543
[TBL] [Abstract][Full Text] [Related]
2. Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival.
Geunes-Boyer S; Oliver TN; Janbon G; Lodge JK; Heitman J; Perfect JR; Wright JR
Infect Immun; 2009 Jul; 77(7):2783-94. PubMed ID: 19451250
[TBL] [Abstract][Full Text] [Related]
3. Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis.
Holmer SM; Evans KS; Asfaw YG; Saini D; Schell WA; Ledford JG; Frothingham R; Wright JR; Sempowski GD; Perfect JR
Infect Immun; 2014 Feb; 82(2):683-93. PubMed ID: 24478083
[TBL] [Abstract][Full Text] [Related]
4. Role of host sphingosine kinase 1 in the lung response against Cryptococcosis.
McQuiston T; Luberto C; Del Poeta M
Infect Immun; 2010 May; 78(5):2342-52. PubMed ID: 20194596
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence.
Davis MJ; Eastman AJ; Qiu Y; Gregorka B; Kozel TR; Osterholzer JJ; Curtis JL; Swanson JA; Olszewski MA
J Immunol; 2015 Mar; 194(5):2219-31. PubMed ID: 25637026
[TBL] [Abstract][Full Text] [Related]
6. Fbp1-mediated ubiquitin-proteasome pathway controls Cryptococcus neoformans virulence by regulating fungal intracellular growth in macrophages.
Liu TB; Xue C
Infect Immun; 2014 Feb; 82(2):557-68. PubMed ID: 24478071
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms.
Giles SS; Zaas AK; Reidy MF; Perfect JR; Wright JR
PLoS One; 2007 Dec; 2(12):e1370. PubMed ID: 18159253
[TBL] [Abstract][Full Text] [Related]
8. Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection.
Gerstein AC; Jackson KM; McDonald TR; Wang Y; Lueck BD; Bohjanen S; Smith KD; Akampurira A; Meya DB; Xue C; Boulware DR; Nielsen K
mBio; 2019 Jul; 10(4):. PubMed ID: 31311883
[TBL] [Abstract][Full Text] [Related]
9. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
[TBL] [Abstract][Full Text] [Related]
10. DAP12 Inhibits Pulmonary Immune Responses to Cryptococcus neoformans.
Heung LJ; Hohl TM
Infect Immun; 2016 Jun; 84(6):1879-86. PubMed ID: 27068093
[TBL] [Abstract][Full Text] [Related]
11. Naïve B cells reduce fungal dissemination in Cryptococcus neoformans infected Rag1
Dufaud C; Rivera J; Rohatgi S; Pirofski LA
Virulence; 2018 Jan; 9(1):173-184. PubMed ID: 28837391
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
[TBL] [Abstract][Full Text] [Related]
13. Core
Thak EJ; Lee SB; Xu-Vanpala S; Lee DJ; Chung SY; Bahn YS; Oh DB; Shinohara ML; Kang HA
mBio; 2020 May; 11(3):. PubMed ID: 32398313
[No Abstract] [Full Text] [Related]
14. Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.
Nakamura Y; Sato K; Yamamoto H; Matsumura K; Matsumoto I; Nomura T; Miyasaka T; Ishii K; Kanno E; Tachi M; Yamasaki S; Saijo S; Iwakura Y; Kawakami K
Infect Immun; 2015 Feb; 83(2):671-81. PubMed ID: 25422263
[TBL] [Abstract][Full Text] [Related]
15. Cdk8 and Ssn801 Regulate Oxidative Stress Resistance and Virulence in Cryptococcus neoformans.
Chang AL; Kang Y; Doering TL
mBio; 2019 Feb; 10(1):. PubMed ID: 30755515
[No Abstract] [Full Text] [Related]
16. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.
Subramaniam KS; Datta K; Quintero E; Manix C; Marks MS; Pirofski LA
J Immunol; 2010 May; 184(10):5755-67. PubMed ID: 20404271
[TBL] [Abstract][Full Text] [Related]
17. Amoeba Predation of Cryptococcus neoformans Results in Pleiotropic Changes to Traits Associated with Virulence.
Fu MS; Liporagi-Lopes LC; Dos Santos SR; Tenor JL; Perfect JR; Cuomo CA; Casadevall A
mBio; 2021 Apr; 12(2):. PubMed ID: 33906924
[TBL] [Abstract][Full Text] [Related]
18. The Membrane Phospholipid Binding Protein Annexin A2 Promotes Phagocytosis and Nonlytic Exocytosis of Cryptococcus neoformans and Impacts Survival in Fungal Infection.
Stukes S; Coelho C; Rivera J; Jedlicka AE; Hajjar KA; Casadevall A
J Immunol; 2016 Aug; 197(4):1252-61. PubMed ID: 27371724
[TBL] [Abstract][Full Text] [Related]
19. Dynamic virulence: real-time assessment of intracellular pathogenesis links Cryptococcus neoformans phenotype with clinical outcome.
Mansour MK; Vyas JM; Levitz SM
mBio; 2011; 2(5):. PubMed ID: 21954307
[TBL] [Abstract][Full Text] [Related]
20. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.
van de Wetering JK; Coenjaerts FE; Vaandrager AB; van Golde LM; Batenburg JJ
Infect Immun; 2004 Jan; 72(1):145-53. PubMed ID: 14688091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
